Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Ann Epidemiol. 2013 Aug 16;24(2):90–97. doi: 10.1016/j.annepidem.2013.07.014

Table 4.

Multivariate logistic regression models for bisphenol-A and ratio of bisphenol-A to creatinine level in relation to hyperglycemia and insulin resistance, stratified by sexa

Hyperglycemia (fasting glucose ≥ 100 mg/dl) Insulin resistance (HOMA-IR ≥ 2.5)

Overall – Bisphenol-A OR (95% CI) OR (95% CI)
Bisphenol-A [continuous]: n=1473 n=1473
1.0 (0.9, 1.2) 1.1 (0.9, 1.3)
PBPA*sex 0.68 0.30
Bisphenol-A [categorical]: Ptrend=0.55 Ptrend=0.23
 Q1: 0.3-<1.0 1.00 1.00
 Q2: 1.0-<2.0 0.9 (0.52, 1.42) 1.1 (0.6, 1.8)
 Q3: 2.0-<3.7 1.2 (0.7, 1.9) 1.7 (1.2, 2.4)
 Q4: ≥ 3.7 1.1 (0.6, 1.9) 1.2 (0.7, 1.9)
PBPA(Q2)*sex 0.32 0.46
PBPA(Q3)*sex 0.15 0.04
PBPA(Q4)*sex 0.81 0.59

Overall – Ratio of bisphenol-A to creatinine OR (95% CI) OR (95% CI)

Bisphenol-A [continuous]: n=1473 n=1473
1.0 (0.9, 1.2) 1.1 (0.9, 1.3)
PBPA*sex 0.14 0.19
Bisphenol-A [categorical]: Ptrend=0.30 Ptrend=0.09
 Q1: 0.001-<0.01 1.00 1.00
 Q2: 0.01-<0.02 1.1 (0.8, 1.6) 0.9 (0.6, 1.4)
 Q3: 0.02-<0.03 1.3 (0.8, 1.9) 1.2 (0.8, 1.7)
 Q4: ≥ 0.03 1.2 (0.8, 1.9) 1.3 (0.9, 1.8)
PBPA(Q2)*sex 0.77 0.81
PBPA(Q3)*sex 0.74 0.72
PBPA(Q4)*sex 0.22 0.34

Males – Bisphenol-A OR (95% CI) OR (95% CI)

Bisphenol-A [continuous]: n=733 n=733
1.1 (0.9, 1.4) 1.2 (1.0, 1.5)
Bisphenol-A [categorical]: Ptrend=0.18 Ptrend=0.12
 Q1: 0.3-<1.0 1.00 1.00
 Q2: 1.0-<2.0 0.8 (0.4, 1.3) 1.3 (0.6, 2.5)
 Q3: 2.0-<3.7 1.7 (0.8, 3.5) 2.7 (1.7, 4.3)
 Q4: ≥ 3.7 1.2 (0.6, 2.6) 1.5 (0.7, 3.2)

Males – Ratio of bisphenol-A to creatinine OR (95% CI) OR (95% CI)

Bisphenol-A [continuous]: n=733 n=733
1.1 (0.9, 1.4) 1.2 (0.9, 1.5)
Bisphenol-A [categorical]: Ptrend=0.12 Ptrend=0.06
 Q1: 0.001-<0.01 1.00
 Q2: 0.01-<0.02 1.0 (0.6, 1.7) 0.9 (0.5, 1.6)
 Q3: 0.02-<0.03 1.2 (0.6, 2.2) 1.3 (0.8, 2.3)
 Q4: ≥ 0.03 1.7 (0.9, 3.5) 1.7 (0.9, 3.3)

Females OR (95% CI) OR (95% CI)

Bisphenol-A [continuous]: n=740 n=740
0.9 (0.7, 1.2) 0.9 (0.8, 1.2)
Bisphenol-A [categorical]: Ptrend=0.59 Ptrend=0.91
 Q1: 0.3-<1.0 1.00 1.00
 Q2: 1.0-<2.0 1.1 (0.6, 2.0) 0.9 (0.5, 1.9)
 Q3: 2.0-<3.7 0.7 (0.3, 1.5) 1.2 (0.6, 2.3)
 Q4: ≥ 3.7 0.9 (0.5, 1.8) 0.9 (0.5, 1.8)

Females – Ratio of bisphenol-A to creatinine OR (95% CI) OR (95% CI)

Bisphenol-A [continuous]: n=740 n=740
0.9 (0.7, 1.2) 0.9 (0.8, 1.1)
Bisphenol-A [categorical]: Ptrend=0.56 Ptrend=0.8
 Q1: 0.001-<0.01 1.00
 Q2: 0.01-<0.02 1.2 (0.6, 2.3) 0.9 (0.5, 1.8)
 Q3: 0.02-<0.03 1.3 (0.6, 2.6) 0.9 (0.5, 1.9)
 Q4: ≥ 0.03 0.9 (0.6, 1.5) 0.9 (0.6, 1.4)
a

All models were adjusted for age (in years), sex (‘male’, ‘female’), race (‘Mexican-American’, ‘Other Hispanic’, ‘Non-Hispanic Black’, ‘Non-Hispanic White’, ‘Other’), Education (‘< High School’, ‘High School’, ‘> High School’), Marital status (‘Ever married’, ‘Never married/Living with partner’), Smoking status (‘Non-smoker’, ‘Ex-smoker’, ‘Current smoker’), Physical activity (metabolic equivalents, in quartiles), Dietary energy intake (kcal, in quartiles), Creatinine (mg/dl, in quartiles) and survey wave (‘2005–2006’, ‘2007–2008’); CI=Confidence Interval; HOMA = Homeostasis Model Assessment; IR=Insulin resistance; OR=odds ratio; Q1=1st quartile; Q2=2nd quartile; Q3=3rd quartile; Q4=4th quartile.

HHS Vulnerability Disclosure